Month: March 2025

Super Hi Reports Unaudited Financial Results for the Fourth Quarter and Full Year 2024

Written by Customer Service on March 25, 2025. Posted in Earnings Releases And Operating Results.

SINGAPORE, March 25, 2025 (GLOBE NEWSWIRE) — Super Hi International Holding Ltd. (NASDAQ: HDL and HKEX: 9658) (“Super Hi” or the “Company”), a leading Chinese cuisine restaurant brand operating Haidilao hot pot restaurants in the international market, today announced its unaudited financial results for the three months (“Fourth Quarter 2024”) and the full year ended December 31, 2024 (“Full Year 2024”). Fourth Quarter 2024 HighlightsRevenue was US$208.8 million, representing an increase of 10.4% from US$189.2 million in the same period of 2023. In the fourth quarter of 2024, the Company opened 2 restaurants and simultaneously closed 1 restaurant to improve the restaurant configuration. The total number of Haidilao restaurants as of December 31, 2024 was 122, reflecting a net increase of 7 since December 31, 2023. Total table...

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

Written by Customer Service on March 25, 2025. Posted in Earnings Releases And Operating Results.

GUANGZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported unaudited financial results for the three months and the year ended December 31, 2024. 2024 Business Overview and Recent UpdatesCorporate UpdatesCompleted profitability-driven organizational optimization, execution towards profitability well underwayEarly Detection THUNDER study for 6-cancer test was included in the Diagnosis and Treatment Guidelines for Primary Liver Cancer (2024 Edition) and the Expert Consensus on Detection and Clinical Application of Tumor DNA Methylation Markers (2024 Edition), showing an impressive performance of ELSA-seq using cfDNA in...

Descartes Acquires 3GTMS

Written by Customer Service on March 25, 2025. Posted in Mergers And Acquisitions.

Strengthens Transportation Management Capabilities for Shippers and Logistics Services Providers WATERLOO, Ontario and ATLANTA, March 25, 2025 (GLOBE NEWSWIRE) — Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, announced that it has acquired 3GTMS (3G), a leading provider of transportation management solutions. Based in the US, 3G’s transportation management solutions combine modern cloud architecture, an expansive carrier network, and planning-driven automation to help customers improve costs, customer satisfaction, and efficiency. Shippers, third-party logistics providers and freight brokers leverage 3G’s platform to optimize domestic over-the-road shipments with tools for planning, rating, consolidation, and routing that cover the entire shipment lifecycle. “3G’s...

O-I Glass Pioneers Sustainable Glassmaking with Successful Biofuel Trial

Written by Customer Service on March 25, 2025. Posted in Public Companies.

Achieved significant reduction in greenhouse gas emissions using 100% biofuel Successfully demonstrated the technical viability of using biofuel at scale Trial was part of the UK government’s “Net Zero Innovation Portfolio” program PERRYSBURG, Ohio /HARLOW, United Kingdom,, March 25, 2025 (GLOBE NEWSWIRE) — — O-I Glass, Inc. (“O-I Glass” or “O-I”) has recently successfully completed a groundbreaking trial in its plant in Harlow, UK, using 100% biofuel to replace natural gas in the furnace for the glass-making process. This achievement is part of a larger initiative led by Glass Futures, a UK-based glass R&D organization, and part of the UK government’s “Net Zero Innovation Portfolio” program, aimed at exploring sustainable fuel options for the industry in the UK. Key Highlights:Significant Reduction...

Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System

Written by Customer Service on March 25, 2025. Posted in Public Companies.

CARLSBAD, Calif., March 25, 2025 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Company’s newest product, the AERO™ Facet Fusion System. The AERO MIS Facet Fusion System is a novel, patent-pending device designed to provide a minimally invasive solution for patients suffering from facet joint-related pain or instability. Cleared for use from spinal levels C2 to S1 (inclusive), the system can be used as a stand-alone facet fusion procedure or as an adjunct to larger spinal fusion surgeries. Engineered for earlier use in the continuum of care, AERO is ideal for patients experiencing mechanical...

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

Written by Customer Service on March 25, 2025. Posted in Earnings Releases And Operating Results.

In February 2025, BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion of Phase 2b study of BX004; topline results anticipated in Q1 2026 Topline Phase 2 results for BX211 in diabetic foot osteomyelitis (DFO) expected by end of March 2025 Initiated exploration and analysis of real-world evidence in people with Cystic Fibrosis (CF) on the relationship between Pseudomonas aeruginosa reduction and clinical outcomes, ahead of expected regulatory discussions in second half of 2025NESS ZIONA, Israel, March 25, 2025 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE, the “Company” or “BiomX”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced financial results for the fourth quarter...

Atour Lifestyle Holdings Limited Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results

Written by Customer Service on March 25, 2025. Posted in Earnings Releases And Operating Results.

A total of 1,619 hotels, or 183,184 hotel rooms, in operation as of December 31, 2024. Net revenues for the fourth quarter of 2024 increased by 38.5% to RMB2,084 million (US$286 million), compared with RMB1,505 million for the same period of 2023. Net revenues for the full year of 2024 increased by 55.3% to RMB7,248 million (US$993 million), compared with RMB4,666 million for the full year of 2023. Net income for the fourth quarter of 2024 increased by 50.5% to RMB331 million (US$45 million), compared with RMB220 million for the same period of 2023. Net income for the full year of 2024 increased by 72.2% to RMB1,273 million (US$174 million), compared with RMB739 million for the full year of 2023. Adjusted net income (non-GAAP)1 for the fourth quarter of 2024 increased by 49.9% to RMB333 million (US$46 million), compared with RMB222 million...

BitFuFu Announces Full Year 2024 Unaudited Financial Results

Written by Customer Service on March 25, 2025. Posted in Earnings Releases And Operating Results.

SINGAPORE, March 25, 2025 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a global leader in Bitcoin mining and comprehensive mining services, today announced its unaudited financial results for the full year ended December 31, 2024. Full Year 2024 Financial HighlightsTotal revenue was US$463.3 million in 2024, representing an increase of 63.1% from US$284.1 million in 2023 Revenue from cloud-mining solutions was US$271.0 million in 2024, representing an increase of 52.2% from US$178.0 million in 2023 Revenue from Bitcoin self-mining operations was US$157.5 million in 2024, representing an increase of 57.2% from US$100.2 million in 2023 Net income was US$54.0 million in 2024, representing an increase of 414.3% from US$10.5 million in 2023 Adjusted EBITDA (a non-GAAP metric) was US$117.5 million in...

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Written by Customer Service on March 25, 2025. Posted in Earnings Releases And Operating Results.

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 4WARD trial protocol refined, increasing confidence in successful outcome 2024 XOLREMDI® net revenues $2.6 million since May launch; company expects ramp up in 2025 as targeted physician outreach increases patient finding and pull-through Conference call and webcast today at 8:30 am ET BOSTON, March 25, 2025 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today reported financial results for the fourth quarter and full year ended December 31, 2024, and highlighted key 2024 and recent events and expected upcoming milestones. “As expected, 2024 was a transformative year...

Pony AI Inc. Announces Unaudited Fourth Quarter and Full Year 2024 Financial Results

Written by Customer Service on March 25, 2025. Posted in Earnings Releases And Operating Results.

NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) — Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in the large-scale commercialization of autonomous mobility, today announced its unaudited financial results for the quarter and full year ended December 31, 2024. Dr. James Peng, Co-founder and Chief Executive Officer of Pony.ai, commented, “2024 marked a milestone year for Pony.ai as we transitioned to a public company. Our robotaxi-first, China-first, and tier-one cities-first approach has positioned us at the forefront of the race towards large-scale commercialization. The strategic partnerships with OEMs we have developed, also empowers us to rapidly scale production of our seventh-generation robotaxi. In 2025, we aim to build upon this momentum and accelerate beyond the inflection point of scaled commercialization,...

Month: March 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals